Torrent Pharmaceuticals Limited Financial Ratios
TORNTPHARM · Healthcare · Current price ₹4,558.9
P/E ratio
71.3x
P/B ratio
22.3x
ROE
25.8%
ROCE
13.9%
Debt / Equity
1.79
Dividend yield
0.8%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 71.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 22.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 25.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 13.9% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.79 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Torrent Pharmaceuticals Limited's latest numbers.
Torrent Pharmaceuticals Limited profitability
Torrent Pharmaceuticals Limited generates a return on equity of 25.8% and a return on capital employed of 13.9%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.79 and a P/E of 71.3x, Torrent Pharmaceuticals Limited is carrying meaningful debt. Our overall business-quality score for the company is 4.9 / 10.
Understand the ratios
More on Torrent Pharmaceuticals Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.